BRPI0909254A2 - cápsula para a prevenção de doenças cardiovasculares - Google Patents

cápsula para a prevenção de doenças cardiovasculares

Info

Publication number
BRPI0909254A2
BRPI0909254A2 BRPI0909254A BRPI0909254A BRPI0909254A2 BR PI0909254 A2 BRPI0909254 A2 BR PI0909254A2 BR PI0909254 A BRPI0909254 A BR PI0909254A BR PI0909254 A BRPI0909254 A BR PI0909254A BR PI0909254 A2 BRPI0909254 A2 BR PI0909254A2
Authority
BR
Brazil
Prior art keywords
capsule
prevention
cardiovascular disease
cardiovascular
disease
Prior art date
Application number
BRPI0909254A
Other languages
English (en)
Inventor
Anna Orriols
Manuel Raga
Marta Guerrero
Pablo Martín
Original Assignee
Ferrer Int
Fundación Ct Nac De Investigaciones Cardiovasculares Carlos Iii
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40010466&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0909254(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferrer Int, Fundación Ct Nac De Investigaciones Cardiovasculares Carlos Iii filed Critical Ferrer Int
Publication of BRPI0909254A2 publication Critical patent/BRPI0909254A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

abstract not avaible
BRPI0909254A 2008-03-28 2009-03-25 cápsula para a prevenção de doenças cardiovasculares BRPI0909254A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08153615 2008-03-28
PCT/EP2009/053545 WO2009118359A2 (en) 2008-03-28 2009-03-25 Capsule for the prevention of cardiovascular diseases

Publications (1)

Publication Number Publication Date
BRPI0909254A2 true BRPI0909254A2 (pt) 2017-01-10

Family

ID=40010466

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0909254A BRPI0909254A2 (pt) 2008-03-28 2009-03-25 cápsula para a prevenção de doenças cardiovasculares

Country Status (34)

Country Link
US (1) US8753680B2 (pt)
EP (1) EP2273985B1 (pt)
JP (1) JP2011515445A (pt)
KR (1) KR20110007602A (pt)
CN (1) CN101980701A (pt)
AR (1) AR071094A1 (pt)
AU (1) AU2009228832A1 (pt)
BR (1) BRPI0909254A2 (pt)
CA (1) CA2720800C (pt)
CL (1) CL2009000767A1 (pt)
CO (1) CO6311069A2 (pt)
CR (1) CR11736A (pt)
CY (1) CY1117556T1 (pt)
DK (1) DK2273985T3 (pt)
EC (1) ECSP10010562A (pt)
ES (1) ES2569553T3 (pt)
GT (1) GT201000275A (pt)
HN (1) HN2010001979A (pt)
HR (1) HRP20160416T1 (pt)
HU (1) HUE028919T2 (pt)
IL (1) IL208455A0 (pt)
IS (1) IS8932A (pt)
MA (1) MA32347B1 (pt)
MX (1) MX2010010479A (pt)
NI (1) NI201000159A (pt)
NZ (1) NZ588239A (pt)
PL (1) PL2273985T3 (pt)
RU (1) RU2477123C2 (pt)
SI (1) SI2273985T1 (pt)
SV (1) SV2010003684A (pt)
TW (1) TW200944251A (pt)
UA (1) UA99758C2 (pt)
UY (1) UY31741A (pt)
WO (1) WO2009118359A2 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201005325A2 (tr) * 2010-06-30 2012-01-23 Bi̇lgi̇ç Mahmut Atorvastatin ve aspirin içeren farmasötik formülasyonlar
FR2967577B1 (fr) * 2010-11-18 2013-07-12 Advicenne Pharma Composition pharmaceutique comprenant du sel de bicarbonate, et son utilisation comme medicament
KR101298788B1 (ko) * 2011-03-15 2013-08-22 보령제약 주식회사 안정성이 개선된 복합제제
KR101378973B1 (ko) * 2012-04-13 2014-03-28 한미약품 주식회사 구형에 가까운 형태의 다중 투여 단위 정제를 포함하는 경질 캡슐 복합 제형 및 이의 제조방법
KR20140030505A (ko) * 2012-08-31 2014-03-12 한미약품 주식회사 이베살탄 및 ＨＭＧ-ＣｏＡ 환원효소 억제제를 포함하는 약제학적 캡슐 복합제제
CN103006612B (zh) * 2012-12-28 2014-07-02 石雷 一种赖诺普利迟释缓释片剂及其制备方法
EP2810644A1 (en) * 2013-06-06 2014-12-10 Ferrer Internacional, S.A. Oral formulation for the treatment of cardiovascular diseases
WO2016139982A1 (ja) * 2015-03-05 2016-09-09 日本電気株式会社 無線設備の故障判定方法及び移動体無線システム
BE1023011B1 (nl) * 2015-08-05 2016-11-04 Nordic Specialty Pharma Bvba Acetylsalicylzuur tablet met onmiddellijke afgifte
ES2695503B2 (es) 2017-06-30 2020-05-08 Pharmalink S L Formulaciones encapsuladas
KR102042626B1 (ko) 2019-06-26 2019-11-11 한미약품 주식회사 이베살탄 및 ＨＭＧ-ＣｏＡ 환원효소 억제제를 포함하는 약제학적 캡슐 복합제제
EP4299063B1 (en) 2022-06-30 2024-05-01 Ferrer Internacional, S.A. Oral capsules comprising atorvastatin tablets showing suitable dissolution profile and bioavailability
CN115671077A (zh) * 2022-11-18 2023-02-03 乐普药业股份有限公司 一种预防心脑血管疾病的复方微丸胶囊及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3739690A1 (de) 1987-11-24 1989-06-08 Hoechst Ag Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen
JP2544052B2 (ja) * 1991-12-18 1996-10-16 日本エランコ株式会社 硬質ゼラチンカプセルへの錠剤充填装置
SE9702000D0 (sv) * 1997-05-28 1997-05-28 Astra Ab New pharmaceutical formulation
US6235311B1 (en) * 1998-03-18 2001-05-22 Bristol-Myers Squibb Company Pharmaceutical composition containing a combination of a statin and aspirin and method
KR20030025903A (ko) * 2000-02-10 2003-03-29 비피에스아이 홀딩스, 인코포레이션. 아크릴 장용 코팅 조성물
US6669955B2 (en) * 2001-08-28 2003-12-30 Longwood Pharmaceutical Research, Inc. Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin
US6576256B2 (en) * 2001-08-28 2003-06-10 The Brigham And Women's Hospital, Inc. Treatment of patients at elevated cardiovascular risk with a combination of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin
WO2004080488A2 (de) 2003-03-10 2004-09-23 Bayer Healthcare Ag Kombinationspräparate von acetylsalicylsäure mit einem hmg-coa-reduktase
CA2531279A1 (en) * 2003-07-28 2005-02-10 Dr. Reddy's Laboratories, Inc. Treatment and preventi0n of cardiovascular events
JP4680061B2 (ja) * 2003-08-20 2011-05-11 塩野義製薬株式会社 新規コーティング組成物
US20070009591A1 (en) * 2005-07-07 2007-01-11 Trivedi Jay S ACE inhibitor formulation
US20070116756A1 (en) * 2005-11-23 2007-05-24 Dr. Reddy's Laboratories Limited Stable pharmaceutical compositions
US7427414B2 (en) 2006-01-18 2008-09-23 Astron Research Limited Modified release oral dosage form using co-polymer of polyvinyl acetate
US20080014271A1 (en) * 2006-07-13 2008-01-17 Ucb, S.A. Novel pharmaceutical compositions comprising levetiracetam
KR100955669B1 (ko) 2007-08-13 2010-05-06 한올바이오파마주식회사 ＨＭＧ­ＣｏＡ 환원효소 저해제와 아스피린을 포함하는 복합제제 및 그의 제조방법

Also Published As

Publication number Publication date
CN101980701A (zh) 2011-02-23
DK2273985T3 (en) 2016-04-25
CO6311069A2 (es) 2011-08-22
CA2720800C (en) 2013-07-30
CY1117556T1 (el) 2017-04-26
IS8932A (is) 2010-10-05
HRP20160416T1 (hr) 2016-06-17
EP2273985A2 (en) 2011-01-19
AU2009228832A1 (en) 2009-10-01
HUE028919T2 (en) 2017-01-30
SI2273985T1 (sl) 2016-06-30
ECSP10010562A (es) 2011-04-29
UY31741A (es) 2009-12-14
RU2010144131A (ru) 2012-05-10
HN2010001979A (es) 2013-07-01
NZ588239A (en) 2011-09-30
EP2273985B1 (en) 2016-02-17
GT201000275A (es) 2015-09-30
WO2009118359A2 (en) 2009-10-01
AR071094A1 (es) 2010-05-26
US8753680B2 (en) 2014-06-17
NI201000159A (es) 2011-08-02
MX2010010479A (es) 2011-02-22
US20110086094A1 (en) 2011-04-14
SV2010003684A (es) 2011-03-31
CA2720800A1 (en) 2009-10-01
UA99758C2 (ru) 2012-09-25
ES2569553T3 (es) 2016-05-11
CL2009000767A1 (es) 2009-08-14
IL208455A0 (en) 2010-12-30
JP2011515445A (ja) 2011-05-19
WO2009118359A3 (en) 2010-05-06
RU2477123C2 (ru) 2013-03-10
TW200944251A (en) 2009-11-01
MA32347B1 (fr) 2011-06-01
KR20110007602A (ko) 2011-01-24
CR11736A (es) 2011-05-11
PL2273985T3 (pl) 2016-08-31

Similar Documents

Publication Publication Date Title
BRPI0909254A2 (pt) cápsula para a prevenção de doenças cardiovasculares
BRPI0920315A2 (pt) capsula para o preparo de uma bebida
BRPI0911299A2 (pt) cápsula para a preparação de uma bebida
BRPI0716384A2 (pt) cÁpsula para a preparaÇço de uma bebida
BRPI1007256A2 (pt) cápsula para o preparo de uma bebida
BRPI0911101A2 (pt) cápsula endoscópica
BR112012000434A2 (pt) procedimento para a fabricação de piscinas naturais.
BR112012000145A2 (pt) construção de uma passarela
FI20095644A0 (fi) Ulokkeen muodostaminen
BRPI0910429A2 (pt) mistura para a produção de comprimidos de desintegração rápida
FI20096192A (fi) Kohteen valaiseminen
FR2943077B1 (fr) Plaque de passage.
BR112012002575A2 (pt) utilização de uma composição.
FR2951357B1 (fr) Chaussures
DOP2010000285A (es) Capsula para la prevencion de enfermedades cardiovasculares
ES1068065Y (es) Blindaje desmontable para maquinaria de obras publicas.
TH901003387A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH901005734A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH901003120A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH901002901A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH901005044A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH901004907A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH901001657A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH903000318A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH901005159A (th) สิทธิบัตรยังไม่ประกาศโฆษณา

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]